Posted by Michael Wonder on 01 Aug 2020
Australians with cancer, infants with epilepsy to benefit from PBS listings
1 August 2020 - Australians with certain cancers and infants with severe epilepsy will benefit from new medications being listed or extended on the Pharmaceutical Benefits Scheme.
From 1 August 2020, up to 130 Australians per year will benefit from the first time listing of Rozlytrek (entrectinib).
In addition, approximately 150 Australians per year will benefit from the first time listing of Lorviqua (lorlatinib).
